Federated Hermes’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-617
| Closed | -$6K | – | 2417 |
|
|
2020
Q3 | $6K | Buy |
617
+15
| +2% | +$143 | ﹤0.01% | 2018 |
|
|
2020
Q2 | $5K | Sell |
602
-14
| -2% | -$107 | ﹤0.01% | 2008 |
|
|
2020
Q1 | $4K | Sell |
616
-201
| -25% | -$1.77K | ﹤0.01% | 1969 |
|
|
2019
Q4 | $10K | Sell |
817
-141,051
| -99% | -$1.54M | ﹤0.01% | 1909 |
|
|
2019
Q3 | $1.64M | Sell |
141,868
-43,246
| -23% | -$455K | ﹤0.01% | 1104 |
|
|
2019
Q2 | $1.85M | Buy |
185,114
+39,965
| +28% | +$431K | ﹤0.01% | 1079 |
|
|
2019
Q1 | $1.87M | Buy |
145,149
+13,132
| +10% | +$196K | ﹤0.01% | 1076 |
|
|
2018
Q4 | $2M | Sell |
132,017
-562
| -0.4% | -$10.7K | 0.01% | 1029 |
|
|
2018
Q3 | $2.65M | Buy |
132,579
+51,137
| +63% | +$1.16M | 0.01% | 1000 |
|
|
2018
Q2 | $1.59M | Sell |
81,442
-18
| -0% | -$398 | ﹤0.01% | 1118 |
|
|
2018
Q1 | $1.64M | Sell |
81,460
-13,199
| -14% | -$223K | ﹤0.01% | 1040 |
|
|
2017
Q4 | $1.25M | Buy |
94,659
+44,741
| +90% | +$675K | ﹤0.01% | 1139 |
|
|
2017
Q3 | $921K | Buy |
49,918
+15,171
| +44% | +$283K | ﹤0.01% | 1221 |
|
|
2017
Q2 | $639K | Sell |
34,747
-672
| -2% | -$13.3K | ﹤0.01% | 1332 |
|
|
2017
Q1 | $799K | Sell |
35,419
-17,395
| -33% | -$416K | ﹤0.01% | 1235 |
|
|
2016
Q4 | $1.84M | Buy |
+52,814
| New | +$1.58M | 0.01% | 904 |
|
|
2016
Q1 | – | Sell |
-1,700
| Closed | -$51K | – | 2205 |
|
|
2015
Q4 | $51K | Buy |
+1,700
| New | +$54.9K | ﹤0.01% | 1687 |
|
|
2015
Q3 | – | Sell |
-60
| Closed | -$4K | – | 2086 |
|
|
2015
Q2 | $4K | Buy |
+60
| New | +$3.77K | ﹤0.01% | 1829 |
|
Federated Hermes's AMAG Position: Q4 2020 in Review
Federated Hermes sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 617 shares — an estimated $6K sold.
Federated Hermes first reported a position in AMAG in Q2 2015 and held it in 18 quarters. The position peaked at $2.65M in Q3 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Federated Hermes reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Federated Hermes sold 617 AMAG Pharmaceuticals shares in Q4 2020, an estimated $6K.
- Federated Hermes first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 18 quarters.
- Federated Hermes's AMAG Pharmaceuticals position peaked at $2.65M in Q3 2018.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.